HIV Pre-Exposure Prophylaxis – Is it just about pills?
HIV Pre-Exposure Prophylaxis – Is it just about pills?
José V. Fernández-Montero
Department of Internal Medicine, Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
*Correspondence: José V. Fernández-Montero, Email not available
Abstract
The increasing use of antiretrovirals for averting HIV infection before potential exposure is under debate. Whereas there is no doubt about the benefit of using Truvada® (tenofovir plus emtricitabine) to reduce HIV acquisition in uninfected persons who have sex with HIV-infected stable partners, concerns are rising about the increasing rate of sexually transmitted infections in subjects engaged in sex with multiple partners, due to misinterpreted self-security.
